Literature DB >> 14671526

Grade I and II acromioclavicular dislocations: results of conservative treatment.

Elyazid Mouhsine1, Raffaele Garofalo, Xavier Crevoisier, Alain Farron.   

Abstract

The purpose of this study was to assess the results of acute grade I and II acromioclavicular (AC) joint sprains treated by conservative measures. Between 1993 and 1997, 37 consecutive patients were treated conservatively for AC joint sprains, grade I and II in the Tossy classification. Of these patients, 4 were excluded (three lost to follow-up and one sustained a further AC injury), leaving a series of 33 patients. Among them, in 9 (27%), chronic AC joint pathology that required subsequent surgery developed at a mean of 26 months after injury. The remaining 24 were reviewed clinically and radiologically at a mean of 6.3 years (range, 4-8 years) after injury. At the latest follow-up, 17 of the 33 patients (52%) remained asymptomatic. Of the 24 patients reviewed, 7 complained of activity-related pain. Eight patients presented with residual anteroposterior instability. Tenderness at the AC joint as well as a positive cross-body test was observed in 12 patients. The mean Constant score at follow-up was 82 points. The x-ray films showed degenerative changes in 13 patients, ossification of the coracoclavicular ligaments in 2, an association of degenerative changes with ossification of the coracoclavicular ligaments in 3, and distal clavicular osteolysis in 3. Only 4 cases had no radiographic changes after this kind of AC injury. On the basis of these results, we conclude that the severity of the consequences after grade I and II AC sprains is underestimated.

Entities:  

Mesh:

Year:  2003        PMID: 14671526     DOI: 10.1016/s1058-2746(03)00215-5

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  28 in total

1.  Managing and recognizing complications after treatment of acromioclavicular joint repair or reconstruction.

Authors:  Richard Ma; Patrick A Smith; Matthew J Smith; Seth L Sherman; David Flood; Xinning Li
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

2.  Rockwood grade I and II acromioclavicular injuries: as benign as commonly believed?

Authors:  Alexander Scott North
Journal:  Joints       Date:  2016-09-21

3.  The Diagnosis and Treatment of Acute Dislocation of the Acromioclavicular Joint.

Authors:  Frank Martetschläger; Natascha Kraus; Markus Scheibel; Jörg Streich; Arne Venjakob; Dirk Maier
Journal:  Dtsch Arztebl Int       Date:  2019-02-08       Impact factor: 5.594

Review 4.  [Current aspects and new techniques in dislocation of the shoulder joint].

Authors:  J Abel; M A Zumstein; L Bolliger; M O Schär
Journal:  Orthopade       Date:  2018-02       Impact factor: 1.087

Review 5.  Shoulder acromioclavicular joint reconstruction options and outcomes.

Authors:  Simon Lee; Asheesh Bedi
Journal:  Curr Rev Musculoskelet Med       Date:  2016-12

6.  Modified Phemister procedure for the surgical treatment of Rockwood types III, IV, V acute acromioclavicular joint dislocation.

Authors:  M A Verdano; A Pellegrini; M Zanelli; M Paterlini; F Ceccarelli
Journal:  Musculoskelet Surg       Date:  2012-08-22

Review 7.  Acromioclavicular joint separations grades I-III: a review of the literature and development of best practice guidelines.

Authors:  Duncan Reid; Kate Polson; Louise Johnson
Journal:  Sports Med       Date:  2012-08-01       Impact factor: 11.136

8.  [Injuries of the acromioclavicular joint in athletes].

Authors:  N Kraus; M Scheibel
Journal:  Chirurg       Date:  2014-10       Impact factor: 0.955

9.  Surgical treatment of acromioclavicular dislocation using the endobutton.

Authors:  Renato Loureiro Teodoro; Alexandre Yukio Nishimi; Luciano Pascarelli; Roberto Rangel Bongiovanni; Marcelo Andreotti Perez Velasco; Eiffel Tsuyoshi Dobashi
Journal:  Acta Ortop Bras       Date:  2017 May-Jun       Impact factor: 0.513

10.  Epidemiology of isolated acromioclavicular joint dislocation.

Authors:  Claudio Chillemi; Vincenzo Franceschini; Luca Dei Giudici; Ambra Alibardi; Francesco Salate Santone; Luis J Ramos Alday; Marcello Osimani
Journal:  Emerg Med Int       Date:  2013-01-28       Impact factor: 1.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.